rebound toxicity after 'treat and release' practices in prehospital opioid overdose care: a systematic review. Emerg Med J. 2019 Apr;36(4):219-224. \[[PubMed: 30580317](https://pubmed.ncbi.nlm.nih.gov/30580317)\] 28. Dahlem CHG, King L, Anderson G, Marr A, Waddell JE, Scalera M. Beyond rescue: Implementation and evaluation of revised naloxone training for law enforcement officers. Public Health Nurs. 2017 Nov;34(6):516-521. \[[PubMed: 28983963](https://pubmed.ncbi.nlm.nih.gov/28983963)\] 29. Wampler DA, Molina DK, McManus J, Laws P, Manifold CA. No deaths associated with patient refusal of transport after naloxone-reversed opioid overdose. Prehosp Emerg Care. 2011 Jul-Sep;15(3):320-4. \[[PubMed: 21612385](https://pubmed.ncbi.nlm.nih.gov/21612385)\] 30. Levine M, Sanko S, Eckstein M. Assessing the Risk of Prehospital Administration of Naloxone with Subsequent Refusal of Care. Prehosp Emerg Care. 2016 Sep-Oct;20(5):566-9. \[[PubMed: 27018626](https://pubmed.ncbi.nlm.nih.gov/27018626)\] 31. Clark AK, Wilder CM, Winstanley EL. A systematic review of community opioid overdose prevention and naloxone distribution programs. J Addict Med. 2014 May-Jun;8(3):153-63. \[[PubMed: 24874759](https://pubmed.ncbi.nlm.nih.gov/24874759)\] 32. Kim HK, Nelson LS. Reducing the harm of opioid overdose with the safe use of naloxone : a pharmacologic review. Expert Opin Drug Saf. 2015 Jul;14(7):1137-46. \[[PubMed: 25865597](https://pubmed.ncbi.nlm.nih.gov/25865597)\] 33. Rzasa Lynn R, Galinkin JL. Naloxone dosage for opioid reversal: current evidence and clinical implications. Ther Adv Drug Saf. 2018 Jan;9(1):63-88. \[[PMC free article: PMC5753997](/pmc/articles/PMC5753997/)\] \[[PubMed: 29318006](https://pubmed.ncbi.nlm.nih.gov/29318006)\] 34. Volkow ND, Jones EB, Einstein EB, Wargo EM. Prevention and Treatment of Opioid Misuse and Addiction: A Review. JAMA Psychiatry. 2019 Feb 01;76(2):208-216. \[[PubMed: 30516809](https://pubmed.ncbi.nlm.nih.gov/30516809)\] 35. Davis CS, Lieberman AJ, Hernandez-Delgado H, Suba C. Laws limiting the prescribing or dispensing of opioids for acute pain in the United States: A national systematic legal review. Drug Alcohol Depend. 2019 Jan 01;194:166-172. \[[PubMed: 30445274](https://pubmed.ncbi.nlm.nih.gov/30445274)\] 36. Gunn AH, Smothers ZPW, Schramm-Sapyta N, Freiermuth CE, MacEachern M, Muzyk AJ. The Emergency Department as an Opportunity for Naloxone Distribution. West J Emerg Med. 2018 Nov;19(6):1036-1042. \[[PMC free article: PMC6225944](/pmc/articles/PMC6225944/)\] \[[PubMed: 30429939](https://pubmed.ncbi.nlm.nih.gov/30429939)\] 37. Elkattawy S, Alyacoub R, Ejikeme C, Noori MAM, Remolina C. Naloxone induced pulmonary edema. J Community Hosp Intern Med Perspect. 2021 Jan 26;11(1):139-142. \[[PMC free article: PMC7850343](/pmc/articles/PMC7850343/)\] \[[PubMed: 33552437](https://pubmed.ncbi.nlm.nih.gov/33552437)\] 38. Brinzo PN, Martins SS. Racial/ethnic trends in opioid and polysubstance opioid overdose mortality in adolescents and young adults, 1999-2020. Addict Behav. 2024 Sep;156:108065. \[[PMC free article: PMC11179956](/pmc/articles/PMC11179956/)\] \[[PubMed: 38772226](https://pubmed.ncbi.nlm.nih.gov/38772226)\] 39. Wang S. Historical Review: Opiate Addiction and Opioid Receptors. Cell Transplant. 2019 Mar;28(3):233-238. \[[PMC free article: PMC6425114](/pmc/articles/PMC6425114/)\] \[[PubMed: 30419763](https://pubmed.ncbi.nlm.nih.gov/30419763)\] 40. Concheiro M, Chesser R, Pardi J, Cooper G. Postmortem Toxicology of New Synthetic Opioids. Front Pharmacol. 2018;9:1210. \[[PMC free article: PMC6212520](/pmc/articles/PMC6212520/)\] \[[PubMed: 30416445](https://pubmed.ncbi.nlm.nih.gov/30416445)\] 41. Miller GE, Moriya